Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynthomer Regulatory News (SYNT)

Share Price Information for Synthomer (SYNT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 286.00
Bid: 286.50
Ask: 291.00
Change: 22.50 (8.54%)
Spread: 4.50 (1.571%)
Open: 262.00
High: 295.00
Low: 262.00
Prev. Close: 263.50
SYNT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Results 2012

28 Aug 2012 07:00

RNS Number : 7916K
Yule Catto & Co PLC
28 August 2012
 



Tuesday 28 August 2012

 

Yule Catto & Co plc

 

Interim Results for the six months ended 30 June 2012

 

SOLID PERFORMANCE IN CHALLENGING MARKET CONDITIONS

 

H1 HIGHLIGHTS *

H1 2012

H1

2011

change

Underlying pro-forma basis

£'m

£'m

%

Sales

603.3

664.3

 (9.2)

Operating Profit (EBIT)

62.1

59.0

5.3

Europe and North America

Asia and ROW

Unallocated

55.7

11.0

(4.6)

45.8

19.0

(5.8)

21.6

(42.1)

20.7

Profit before Tax

56.0

52.4

6.9

Underlying basis

EPS (p)

12.3

9.5

29.5

DPS (p)

2.2

1.2

83.3

 

·; Solid Group performance despite challenging macroeconomic conditions and tough trading environment in Asian nitrile markets

 

·; Strong performance in Europe and North America reflecting underlying profit growth and the benefits of the PolymerLatex acquisition synergies

 

·; £9 million of synergies from PolymerLatex in H1; on track to deliver £25 million of total synergies by March 2013

 

·; Asia and ROW impacted by previously announced competitive environment in nitrile latex, with continued good levels of growth across other businesses

 

·; 83.3% increase in interim dividend reflects commitment to deliver a progressive dividend policy

 

·; Strong balance sheet; Net debt reduced to £174 million (H1 2011: £240 million)

 

·; Board strengthened by appointments of Ishbel Macpherson and Dr. Just Jansz

 

* All numbers on an underlying basis. 2011 comparatives, other than EPS, are adjusted to a pro-forma basis

 

 

Commenting on the results, Adrian Whitfield, Group Chief Executive, said:

 

"We have delivered a solid set of results in a challenging environment driven by a strong performance in Europe and North America, which accounted for 84% of our profits. The PolymerLatex acquisition has significantly enhanced our product portfolio and reach, as well as provided additional cash resources which we are using to invest in emerging markets and innovation to position us for future growth.

 

As previously announced, the nitrile latex business experienced a difficult competitive environment, driving a weaker performance in that part of our Asia and ROW business, with the rest of the portfolio making good progress.

 

Assuming there is no further deterioration in the global economy, the Board's expectations remain unchanged from the June trading update, for full year underlying profit before tax ahead of 2011 pro-forma of £96 million."

 

 

 

ENQUIRIES:

 

Adrian Whitfield, Group Chief Executive

Charles Armitstead / Rosie Oddy

David Blackwood, Group Finance Director

Pendomer Communications

Tel: 01279 442791

Tel: 020 3603 5220

 

Adrian Whitfield, Group Chief Executive, and David Blackwood, Group Finance Director will be presenting the Company's results at a meeting for analysts and investors at 09.30 at the offices of Canaccord Genuity (88 Wood Street, London, EC2V 7QR). The presentation will be webcast on the company's website www.yulecatto.com 

 

Calculation of pro-forma numbers and IFRS information:

 

Underlying

IFRS

Six months ended

30 June 2011

Six months ended

30 June 2012

Six months ended

30 June 2012

Six months ended

30 June 2011

As reported

PolymerLatex

Pro-forma

Q1 2011

£'000

£'000

£'000

£'000

£'000

£'000

Total sales

(including share of JV's)

512,296

151,982

664,278

603,297

603,297

512,296

Europe and North America

33,463

12,362

45,825

55,706

41,875

22,666

Asia and ROW

18,089

920

19,009

10,959

7,838

17,059

Unallocated

(5,880)

-

(5,880)

(4,576)

(4,576)

(6,726)

Operating profit (including share of JV's)

45,672

13,282

58,954

62,089

45,137

32,999

Finance costs

(4,471)

(2,100)

(6,571)

(6,073)

(6,898)

(6,305)

Profit before taxation

41,201

11,182

52,383

56,016

38,239

26,694

Taxation

(8,141)

(3,243)

(11,384)

(13,432)

(10,013)

(2,186)

Discontinued operations

-

-

-

-

-

(35,207)

Profit for the period

33,060

7,939

40,999

42,584

28,226

(10,699)

Profit attributable to minority interests

844

-

844

897

604

844

Profit attributable to equity holders of parent

32,216

7,939

40,155

41,687

27,662

(11,543)

33,060

7,939

40,999

42,584

28,226

(10,699)

 

The pro-forma adjustment in this report reflects the inclusion of the unaudited results of PolymerLatex for the first quarter of 2011 (pre acquisition period) restated to Yule Catto's accounting policies. An estimate of the impact on finance costs if the business had been owned for that period has been made at the rate of £2.1 million per quarter.

 

Yule Catto & Co plc (YULC.L) may also be referred to in this report as "Yule Catto", the "Company" or the "Group"

 

Cautionary statement

This Interim Management Report (IMR) has been prepared solely to provide additional information to shareholders to assess the Group's strategies and the potential for those strategies to succeed. The IMR should not be relied on by any other party or for any other purpose.

The IMR contains certain forward-looking statements. These statements are made by the directors in good faith based on the information available to them up to the time of their approval of this report and such statements should be treated with caution due to the inherent uncertainties, including both economic and business risk factors, underlying any such forward-looking information.

This IMR and the consolidated financial statements for the six months ended 30 June 2012 and for the six months ended 30 June 2011 have been reviewed but not audited. All reference to sales and operating profit in the Chairman's statement and business review, which follows, reflect underlying performance including share of joint ventures, as per note 4, unless otherwise stated.

 

CHAIRMAN'S STATEMENT

 

Overview

The Group delivered a solid set of results for the first half of 2012 despite a very difficult economic environment, a £2.5 million adverse translation impact of the euro, and the competitive environment in our nitrile latex business in Asia.

 

As expected, the acquisition of PolymerLatex has significantly benefited our business in Europe, delivering increased scale, an enhanced product portfolio, stronger market positions and greater efficiencies. The strength of our business in Europe underpins Yule Catto's long-term growth strategy providing the necessary cash generation to accelerate its growth into emerging markets.

 

H1 Results*

Group revenues declined by 9.2% to £603.3 million (2011: £664.3 million), mainly due to the impact of volumes which were 9.5% lower than H1 2011. However, Group EBIT increased by 5.3% to £62.1 million (2011: £59.0 million) due to synergies achieved from the PolymerLatex acquisition and good margin management across our European business. This more than offset the weak results in nitrile and the effect of the weaker euro.

Underlying profit before tax increased to £56.0 million, 6.9% ahead of prior year on a pro-forma basis and 36.0% ahead on a non pro-forma basis.

 

Earnings per share for the half year, on an underlying basis, were 12.3 pence per share, 29.5% ahead of prior year.

 

As reported at the time of our full year 2011 results in March, we now expect to achieve a run rate of synergy benefits of £25 million by March 2013. This will result in £16 million benefit to full year 2012 operating profit compared to 2011 with a further £6 million year on year benefit in 2013. Some £3 million of benefits were delivered in 2011. The synergy process remains on plan, and the benefits can clearly be seen in the results of our European and North American business segment.

 

*We have set out the interim results on a pro-forma basis to provide a clear like-for-like comparison on the prior period. All comments in this Chairman's statement refer to pro forma numbers unless otherwise stated. The pro-forma adjustment in this report reflects the inclusion of the unaudited results of PolymerLatex for the first quarter of 2011 restated to Yule Catto's accounting policies. An estimate of the impact on finance costs if the business had been owned for that period has been made at the rate of £2.1 million per quarter.

 

Divisional Performance

Europe & North America (on an underlying pro-forma basis)

H1 2012

H1 2011

Sales (£'m)

438.2

479.0

Operating Profit (£'m)

55.7

45.8

 

Our business in Europe and North America delivered a substantial increase in operating profit, as a result of underlying profit growth and the synergies we have achieved to date from the PolymerLatex acquisition.

 

Volumes were down by 11.5% on the first half of 2011. This was partly due to margin management, but mainly as a result of a further slowdown in the European economy generally, particularly in the construction industry.

 

Raw material prices were volatile during the period, increasing through the first quarter and peaking by May, and have since fallen sharply. We continue to mitigate the impact of this volatility through the active management of selling prices and unit margins as we have done over recent years.

 

Asia & Rest of World (on an underlying pro-forma basis)

H1 2012

H1 2011

Sales (£'m)

165.1

185.3

Operating Profit (£'m)

11.0

19.0

 

As flagged in our May interim management statement and our June trading update, the nitrile market in Asia has become extremely challenging, with excess capacity and aggressive competitive behaviour. As a result, operating profit in Asia and ROW declined 42.1%, on volumes down by 4.2% against a very strong comparative prior year period. The balance of our business, which accounts for circa 50% of revenues in Asia & ROW performed well, with EBIT ahead 18%.

 

The outlook for nitrile remains unchanged from the update we provided in June, and we do not foresee any meaningful recovery in the trading environment in the next 12 to 18 months. The Group has experienced a drop in market share in nitrile as the competitive environment has developed and this is affecting margins. The Group remains the overall global market leader with around one third of the market.

 

We remain confident about the underlying long term attractiveness of the high growth Asian nitrile latex glove market. We continue to invest for future growth in this region to improve efficiency, capacity and geographic reach across our entire product range.

 

Balance sheet

The Group's financial position remains robust, with net borrowings down to £174.2 million from £240.4 million at the midpoint of 2011. Net debt was slightly up on the year end position of £164.3 million, primarily as a result of a substantial increase in working capital over and above the normal seasonal outflow from the year end, reflecting the effect of the higher input prices. This was similar to what we saw in 2011 when a rapid first half escalation in raw material prices affected working capital. Operating levels as a percentage of sales remained broadly unchanged.

 

There was no significant change in the level of the Group's pension deficit from the start of the year.

 

At the end of June, the Group had net liquid resources available of £13.8 million (cash and equivalents less short term borrowings) and an undrawn £60.0 million revolving credit line maturing in March 2015 together with various uncommitted overdraft lines.

 

Dividend

The Board has considered future dividend policy and intends to target a dividend cover of three times by 2015. For 2012 the Board expects to declare a total dividend of 5.5p and progressively move towards the 2015 target.

 

Consistent with this we are declaring an interim dividend of 2.2p.

 

IFRS

The Group reported an IFRS profit before tax of £38.2 million (2011 - £26.7 million). This is £17.8 million below underlying profit before tax (2011 - £14.5 million) due to the special items detailed in the 'Special Items' paragraph below.

 

Special items

The Group had a number of special items in the half year, which are not part of underlying results. The operating expense amount of £17.0 million relates to the PolymerLatex acquisition, comprising £3.1 million of restructuring expenses associated with the continuing integration and synergy extraction and £13.9 million of intangible amortisation. The loss on fair value within finance costs of £0.8 million relates to the cross currency swaps that hedge the Group's US private placement debt into sterling, but do not qualify for hedge accounting under the narrow framework of IAS 39. The majority of the taxation amount of £3.4 million is the notional tax credit on the intangible amortisation expense.

 

Taxation

The Group benefits from tax holiday arrangements in the nitrile business in Malaysia and no tax is usually payable in the UK, as a result of contributions to the closed defined benefit UK pension fund. The increase in profits earned in Germany with its relatively high tax rate, following the PolymerLatex acquisition and subsequent integration, has resulted in an overall underlying taxation rate of 24%.

 

Risks and uncertainties

There are a number of potential risks and uncertainties which could have a material impact on the Group's performance over the remaining six months of the financial year and could cause actual results to differ materially from expected and historical results. The directors do not consider that the principal risks and uncertainties have changed since the publication of the annual report for the year ended 31 December 2011. These risks include:

 

• Conditions in the global economy, economic fluctuations in customer industries and volatility and cyclicality of the global chemicals and polymers markets may adversely affect the results of operations, financial condition and cash flows of the Group;

• Volatility in raw material prices and energy prices may adversely affect the profitability of the Group and its working capital position;

• The failure of the Group to procure key raw materials may lead to production interruptions that may adversely affect the profitability of the Group and its working capital position;

• The markets in which the Group operates are highly competitive and the Group may lose market share to other producers or sellers of water based polymers or to other products that can be substituted for the products of the Group;

·; The Group operates in a number of different geographies which may present different legal and regulatory risks. In addition, the Group operates in a number of different tax regimes, which may increase the volatility of the effective tax rate and cash tax rate of the Group;

• The ability of the Group to compete is highly dependent on its ability to develop technological innovations, to introduce new products and to protect its intellectual property, trade secrets and know-how. Failure to do so could have an adverse affect on the Group;

• The Group may be liable for damages based on product liability claims brought against its customers in end-use markets. In addition, compliance with extensive environmental, health and safety laws and regulations could require material expenditure, changes in the operations of the Group or site remediation;

 • The manufacture, storage and transportation of chemicals is inherently dangerous and any incidents relating to the hazards which the Group faces may adversely affect its financial condition, results of operations and reputation;

• Fluctuations in currency exchange rates may significantly impact the results of the operations of the Group and may significantly affect the comparability of financial results between financial periods;

• Credit market conditions and credit ratings may restrict the ability of the Group to obtain credit facilities or to refinance its existing debt facilities in the longer term. In addition, interest rate fluctuations and increases in bank lending margins may increase the Group's costs of borrowing in the longer term;

• The carrying value of goodwill and non-current assets is sensitive to changes in estimates of future growth rates and discount rates; and

• The Group has funding risks relating to defined benefit pension schemes and any deterioration in the value of assets in which the pension scheme has invested as against the financial obligations to make payments to members of the schemes could have an adverse affect on the Group. Changes in interest rates will also affect the Group's pension liabilities.

 

The Group continues to manage these risks as set out in the annual report.

 

Outlook

The Board remains cautious regarding the wider economic outlook, given continuing issues in the eurozone and their effect on the global economy. However, Yule Catto's strong portfolio of market leading products, our high percentage of sales into Asia and other developing economies, and the near term synergy benefits from PolymerLatex, all underpin the Board's confidence in the Group's prospects for the longer term.

 

Assuming there is no further deterioration in the global economy, the Board's expectations remain unchanged from the June trading update, for full year underlying profit before tax ahead of 2011 pro-forma of £96 million.

 

 

 

 

NEIL JOHNSON

Chairman

28 August 2012

CONsolidated income statement for the SIX MONTHS ENDED 30 JUNE 2012

 

 

Six months ended 30 June 2012

 

Six months ended 30 June 2011

Underlying performance

Special items

IFRS

Underlying performance

Special items

IFRS

£'000

£'000

£'000

£'000

£'000

£'000

Unaudited

Unaudited

Unaudited

Unaudited

Unaudited

Unaudited

Continuing operations

Group revenue

570,574

-

570,574

488,576

-

488,576

Share of joint ventures' revenue

32,723

-

32,723

23,720

-

23,720

Total sales

603,297

-

603,297

512,296

-

512,296

Group revenue

570,574

-

570,574

488,576

-

488,576

Company and subsidiaries before special items

59,100

-

59,100

43,482

-

43,482

Restructuring and site closure

-

(3,093)

(3,093)

-

(4,516)

(4,516)

Acquisition costs

-

-

-

-

(846)

(846)

Amortisation of acquired intangibles

-

(13,049)

(13,049)

-

(6,880)

(6,880)

Company and subsidiaries

59,100

(16,142)

42,958

43,482

(12,242)

31,240

Share of joint ventures

2,989

(810)

2,179

2,190

(431)

1,759

Operating profit / (loss)

62,089

(16,952)

45,137

45,672

(12,673)

32,999

Interest payable

(6,858)

-

(6,858)

(4,926)

-

(4,926)

Interest receivable

785

-

785

455

-

455

(6,073)

-

(6,073)

(4,471)

-

(4,471)

Fair value adjustment

-

(825)

(825)

-

(1,834)

(1,834)

Finance costs

(6,073)

(825)

(6,898)

(4,471)

(1,834)

(6,305)

Profit/(loss) before taxation

56,016

(17,777)

38,239

41,201

(14,507)

26,694

Taxation

(13,432)

3,419

(10,013)

(8,141)

5,955

(2,186)

Profit/(loss) for the period

42,584

(14,358)

28,226

33,060

(8,552)

24,508

Discontinued operations

Loss for the year from discontinued operations

-

-

-

-

(35,207)

(35,207)

Profit / (loss) for the period

42,584

(14,358)

28,226

33,060

(43,759)

(10,699)

Profit attributable to minority interests

897

(293)

604

844

-

844

Profit / (loss) attributable to equity holders of the parent

41,687

(14,065)

27,622

32,216

(43,759)

(11,543)

42,584

(14,358)

28,226

33,060

(43,759)

(10,699)

Earnings per share

From continuing operations

Basic

12.3p

(4.2)p

8.1p

9.5p

(2.5)p

7.0p

Diluted

12.1p

(4.1)p

8.0p

9.3p

(2.5)p

6.8p

Special items

The special items are shown in more detail in note 3.

 

Consolidated income statement for the SIX MONTHS ENDED 30 JUNE 2012 continued

 

 

Year ended 31 December 2011

Underlying performance

Special items

IFRS

£'000

£'000

£'000

Audited

Audited

Audited

Continuing operations

Group revenue

1,059,438

-

1,059,438

Share of joint ventures' revenue

57,424

-

57,424

Total sales

1,116,862

-

1,116,862

Group revenue

1,059,438

-

1,059,438

Company and subsidiaries before special items

91,549

-

91,549

Restructuring and site closure

-

(20,230)

(20,230)

Acquisition costs

-

(1,427)

(1,427)

Amortisation of acquired intangibles

-

(19,096)

(19,096)

Company and subsidiaries

91,549

(40,753)

50,796

Share of joint ventures

4,819

(1,286)

3,533

Operating profit /(loss)

96,368

(42,039)

54,329

Interest payable

(12,312)

-

(12,312)

Interest receivable

739

-

739

(11,573)

-

(11,573)

Fair value adjustment

-

(3,317)

(3,317)

Finance costs

(11,573)

(3,317)

(14,890)

Profit/(loss) before taxation

84,795

(45,356)

39,439

Taxation

(19,438)

14,955

(4,483)

Profit/ (loss) for the year from continuing operations

65,357

(30,401)

34,956

Discontinued operations

(Loss) / profit for the year from discontinued operations

-

(40,257)

(40,257)

Profit / (Loss) for the year

65,357

(70,658)

(5,301)

Profit attributable to minority interests

1,645

-

1,645

Profit attributable to equity holders of the parent

63,712

(70,658)

(6,946)

65,357

(70,658)

(5,301)

Earnings per share

From continuing operations

Basic

18.8p

(9.0)p

9.8p

Diluted

18.4p

(8.8)p

9.6p

 

Special items

The special items are shown in more detail in note 3.

 

Consolidated STATEMENT OF COMPREHENSIVE INCOME for the SIX MONTHS ENDED 30 June 2012

Six months ended 30 June 2012

Six months ended 30 June 2011

Equity holders of the parent

Minority interests

Total

Equity holders of the parent

Minority interests

Total

Unaudited

Unaudited

Unaudited

Unaudited

Unaudited

Unaudited

£'000

£'000

£'000

£'000

£'000

£'000

Profit / (loss) for the period

27,622

604

28,226

(11,543)

844

(10,699)

Actuarial gains / (losses)

(3,163)

-

(3,163)

1,959

-

1,959

(Losses) / gains on cash flow hedges arising during the period

111

-

111

(4,495)

-

(4,495)

Exchange differences on translation of foreign operations

(8,368)

(186)

(8,554)

9,417

(168)

9,249

(Losses) / gains on a hedge of a net investment taken to equity

1,374

-

1,374

(1,814)

-

(1,814)

Tax relating to components of other comprehensive income

-

-

-

-

-

-

Other comprehensive income for the period

(10,046)

(186)

(10,232)

5,067

(168)

4,899

Total comprehensive income for the period

17,576

418

17,994

(6,476)

676

(5,800)

 

 

Year ended 31 December 2011

Equity holders of the parent

Minority interests

Total

Audited

Audited

Audited

£'000

£'000

£'000

(Loss) / profit for the year

(6,946)

1,645

(5,301)

Actuarial gains / (losses)

(33,959)

-

(33,959)

(Losses) / gains on a cash flow hedges arising during the period

(7,344)

-

(7,344)

Exchange differences on translation of foreign operations

(4,402)

(202)

(4,604)

(Losses) / gains of a hedge of a net investment taken into equity

509

-

509

Tax relating to components of other comprehensive income

1,295

-

1,295

Other comprehensive income for the year

(43,901)

(202)

(44,103)

Total comprehensive income for the year

(50,847)

1,443

(49,404)

 

 

Consolidated STATEMENT OFCHANGES IN EQUITY

 

Share capital

Share premium

Capital redemption reserve

Own shares

Hedging and translation reserve

Cash flow hedging reserve

Retained earnings

Total

Minority interest

Total equity

£'000

£'000

£'000

£'000

£'000

£'000

£'000

£'000

£'000

£'000

At 1 January 2012

33,988

230,534

949

-

2,935

(2,849)

(1,046)

264,511

10,612

275,123

(Loss) / profit for the period

-

-

-

-

-

-

27,622

27,622

604

28,226

Other comprehensive income for the period

-

-

-

-

(6,994)

111

(3,163)

(10,046)

(186)

(10,232)

Total comprehensive income for the period

-

-

-

-

(6,994)

111

24,459

17,576

418

17,994

Share based payments

-

-

-

-

-

-

(6,024)

(6,024)

-

(6,024)

At 30 June 2012 (Unaudited)

33,988

230,534

949

-

(4,059)

(2,738)

17,389

276,063

11,030

287,093

 

 

Share capital

Share premium

Capital redemption reserve

Own shares

Hedging and translation reserve

Cash flow hedging reserve

Retained earnings

Total

Minority interest

Total equity

£'000

£'000

£'000

£'000

£'000

£'000

£'000

£'000

£'000

£'000

At 1 January 2011

14,566

33,034

949

-

6,828

4,495

46,444

106,316

6,249

112,565

(Loss) / profit for the period

-

-

-

-

-

-

(11,543)

(11,543)

844

(10,699)

Other comprehensive income for the period

-

-

-

-

7,603

(4,495)

1,959

5,067

(168)

4,899

Total comprehensive income for the period

-

-

-

-

7,603

(4,495)

(9,584)

(6,476)

676

(5,800)

Issue of share capital

19,422

205,871

-

-

-

-

-

225,293

-

225,293

Expenses on issue of share capital

-

(8,371)

-

-

-

-

-

(8,371)

-

(8,371)

At 30 June 2011 (Unaudited)

33,988

230,534

949

-

14,431

-

36,860

316,762

6,925

323,687

 

 

Share capital

Share premium

Capital redemption reserve

Own shares

Hedging and translation reserve

Cash flow hedging reserve

Retained earnings

Total

Minority interest

Total equity

£'000

£'000

£'000

£'000

£'000

£'000

£'000

£'000

£'000

£'000

At 1 January 2011

14,566

33,034

949

-

6,828

4,495

46,444

106,316

6,249

112,565

(Loss) / profit for the year

-

-

-

-

-

-

(6,946)

(6,946)

1,645

(5,301)

Other comprehensive income for the period

-

-

-

-

(3,893)

(7,344)

(32,664)

(43,901)

(202)

(44,103)

Total comprehensive income for the period

-

-

-

-

(3,893)

(7,344)

(39,610)

(50,847)

1,443

(49,404)

Dividends paid

-

-

-

-

-

-

(8,489)

(8,489)

-

(8,489)

Investment by minority interest

-

-

-

-

-

-

-

-

2,920

2,920

Issue of share capital

19,422

205,871

-

-

-

-

-

225,293

-

225,293

Expenses on issue of share capital

-

(8,371)

-

-

-

-

-

(8,371)

-

(8,371)

Shares purchased by ESOP trust

-

-

-

659

-

-

-

659

-

659

Share-based payments

(659)

-

-

609

(50)

-

(50)

At 31 December 2011 (Audited)

33,988

230,534

949

-

2,935

(2,849)

(1,046)

264,511

10,612

275,123

 

 

Consolidated balance sheet as at 30 June 2012

30 June 2012

30 June 2011

31 December 2011

Unaudited

Unaudited

Audited

£'000

£'000

£'000

Non-current assets

Goodwill

239,298

252,591

244,690

Acquired intangible assets

147,042

179,527

165,366

Other intangible assets

668

3,838

863

Property, plant and equipment

185,663

222,316

183,599

Financial asset

5,394

-

5,589

Deferred tax assets

1,162

158

1,116

Investment in joint ventures

13,196

14,422

14,325

Total non-current assets

592,423

672,852

615,548

Current assets

Inventories

73,087

102,524

73,825

Trade and other receivables

183,941

202,200

146,692

Cash and cash equivalents

56,291

41,639

85,922

Derivatives at fair value

15,620

14,511

17,368

Total current assets

328,939

360,874

323,807

Current liabilities

Borrowings

(27,767)

(6,833)

(31,739)

Trade and other payables

(187,844)

(239,454)

(193,630)

Current tax liability

(41,202)

(41,318)

(37,864)

Derivatives at fair value

(4,881)

(5,328)

(5,628)

Total current liabilities

(261,694)

(292,933)

(268,861)

Non-current liabilities

Borrowings

(199,830)

(253,155)

(215,901)

Trade and other payables

(156)

-

(181)

Deferred tax liability

(56,122)

(72,294)

(61,379)

Post retirement benefit obligations

(116,467)

(91,657)

(117,910)

Total non-current liabilities

(372,575)

(417,106)

(395,371)

Net assets

287,093

323,687

275,123

Equity

Called up share capital

33,988

33,988

33,988

Share premium

230,534

230,534

230,534

Capital redemption reserve

949

949

949

Hedging and translation reserve

(4,059)

14,431

2,935

Cash flow hedging reserve

(2,738)

-

(2,849)

Retained earnings

17,389

36,860

(1,046)

Equity attributable to equity holders of the parent

276,063

316,762

264,511

Minority interests

11,030

6,925

10,612

Total equity

287,093

323,687

275,123

Analysis of net borrowing

Cash and cash equivalents

56,291

41,639

85,922

Current borrowings

(27,767)

(6,833)

(31,739)

Financial asset

5,394

-

5,589

Non-current borrowings

(199,830)

(253,155)

(215,901)

Net borrowings

(165,912)

(218,349)

(156,129)

Special item: deduct fair value adjustment

11,859

9,684

12,759

Special item: add non-recourse factoring

(20,132)

(31,773)

(20,955)

Net borrowings (underlying performance)

(174,185)

(240,438)

(164,325)

The Group's US private placement US dollar term debt was economically hedged from dollars into sterling using long dated cross currency swaps at the date it was borrowed. The US dollar term debt is shown at the 30 June 2012 spot rate in net borrowings. The mark to market of the currency element of these swaps which hedges this US dollar term debt is shown as a reconciling item in the above analysis.

The 30 June 2011 balance sheet has been revised, see note 10.

The financial statements were approved by the Board of Directors and authorised for issue on 28 August 2012.

 

Consolidated cash flow STATEMENT for the SIX MONTHS ENDED 30 JUNE 2012

 

Six months ended 30 June 2012

 Six months ended 30 June 2011

Year ended 31 December 2011

Unaudited

Unaudited

Unaudited

Unaudited

Audited

Audited

 

£'000

£'000

£'000

£'000

£'000

£'000

 

Operating

 

Cash generated from operations

16,440

13,828

80,191

 

Interest received

785

455

739

 

Interest paid

(6,883)

(6,728)

(15,954)

 

Net interest paid

(6,098)

(6,273)

(15,215)

 

UK corporation tax paid

(38)

(27)

(52)

 

Overseas corporate tax paid

(8,605)

(10,500)

(19,878)

 

Total tax paid

(8,643)

(10,527)

(19,930)

 

Net cash (outflow) / inflow from operating activities

1,699

(2,972)

45,046

 

 

Investing

 

Dividends received from joint ventures

411

809

3,399

 

Purchase of property, plant and equipment

(16,595)

(10,099)

(24,248)

 

Sale of property, plant and equipment

70

3

2,327

 

Net capital expenditure and financial investment

(16,525)

(10,096)

(21,921)

 

Purchase of business

-

(352,208)

(365,379)

 

Sale of businesses

-

-

28,460

 

Net cash impact of acquisitions and disposals

-

(352,208)

(336,919)

 

Net cash (outflow) / inflow from investing activities

(16,114)

(361,495)

(355,441)

 

 

Financing

 

Equity dividends paid

-

-

(8,489)

 

Investment by minority shareholder

-

-

2,920

 

Proceeds on issue of shares

-

225,293

225,293

 

Expenses on issue of shares

-

(8,371)

(8,371)

 

Purchase of own shares

-

-

(659)

 

Repayment of borrowings

(3,918)

(1,927)

(4,340)

 

(Repayments) / proceeds of non-current borrowings

(9,706)

153,401

154,100

 

Net cash inflow / (outflow) from financing activities

(13,624)

368,396

360,454

 

 

(Decrease) / increase in cash and bank overdrafts during the period

(28,039)

3,929

50,059

 

 

Comprised of:

 

Cash and cash equivalents

(27,682)

1,651

42,208

 

Bank overdrafts

(357)

2,278

7,851

 

(28,039)

3,929

50,059

 

 

 

 

RECONCILIATION OF NET CASH FLOW FROM OPERATING ACTIVITIES TO MOVEMENT IN NET DEBT FOR THE SIX MONTHS ENDED 30 JUNE 2012

 

Six months ended

30 June 2012

Six months ended

30 June 2011

Year ended

31 December 2011

Unaudited

Unaudited

Audited

£'000

£'000

£'000

Net cash inflow / (outflow) from operating activities

1,699

(2,972)

45,046

Add back: reduction in factored invoices

-

-

9,807

Add back: dividends received from joint ventures

411

809

3,399

Less: net capital expenditure and financial investment

(16,525)

(10,096)

(21,921)

(14,415)

(12,259)

36,331

Net cash impact of acquisitions (underlying)

-

(382,970)

(396,141)

Net cash impact of disposals (underlying)

-

-

34,178

Investment by minority shareholder

-

-

2,920

Proceeds on issue of shares

-

225,293

225,293

Expenses on issue of shares

-

(8,371)

(8,371)

Purchase of own shares

-

-

(659)

Equity dividends paid

-

-

(8,489)

Exchange movements

4,555

1,239

13,983

Movement in net borrowings (underlying performance)

(9,860)

(177,068)

(100,955)

 

 

NOTES TO THE FINANCIAL STATEMENTS

 1. General information

The information for the year ended 31 December 2011 does not constitute statutory accounts as defined in section 434 of the Companies Act 2006. A copy of the statutory accounts for that year has been delivered to the Registrar of Companies. The auditors' report on those accounts was not qualified, did not contain a reference to any matters which the auditor drew attention by way of emphasis without qualifying the report, and did not contain statements under section 498(2) or (3) of the Companies Act 2006.

 

2. Accounting policies

The annual financial statements of Yule Catto & Co plc are prepared in accordance with IFRSs as adopted by the European Union. The condensed set of financial statements included in the half-yearly financial report has been prepared in accordance with International Accounting Standards 34 'Interim Financial Reporting', as adopted by the European Union. The same accounting policies and methods of computations are followed in these financial statements as in the most recent audited annual financial statements.

 

Having regard to the financial position and future prospects of the Group, the directors have concluded that the Group is a going concern and have prepared these financial statements on that basis.

 

3. Special items

The special items disclosed are made up as follows:

 

Six months ended

30 June 2012

Six months ended

30 June 2011

Year ended

31 December 2011

£'000

£'000

£'000

Unaudited

Unaudited

Audited

Continuing operations

Operating (loss) / profit

Restructuring and site closure - cash costs

(2,456)

(4,516)

(15,792)

- non-cash costs

(637)

-

(4,438)

(3,093)

(4,516)

(20,230)

Acquisition costs

-

(846)

(1,427)

Amortisation of acquired intangibles - subsidiaries

(13,049)

(6,880)

(19,096)

- share of joint ventures

(810)

(431)

(1,286)

(16,952)

(12,673)

(42,039)

Finance costs

Fair value adjustment

(825)

(1,834)

(3,317)

(Loss) / profit before taxation from continuing operations

(17,777)

(14,507)

(45,356)

Taxation

3,419

5,955

14,955

(Loss) / profit for the year from continuing operations

(14,358)

(8,552)

(30,401)

Discontinued operations

Total sales

Revenue of operations sold or closed during the period

-

35,381

63,115

Operating (loss) / profit of discontinued operations

Operating profit of operations sold or closed during the year

-

2,291

4,124

Impairment of goodwill

-

(36,885)

(36,885)

Impairment of fixed assets prior to sale of operation

-

-

(5,620)

Loss arising from the sale or closure of operations

-

-

(813)

-

(34,594)

(39,194)

Taxation on operating profit of operations sold or closed during the year

-

(613)

(1,063)

(Loss) / profit for the year from discontinued operations

-

(35,207)

(40,257)

 

 

 

4. Segmental analysis

 

Total sales*

Operating profit

Underlying performance

Special items

IFRS

Underlying performance

Special items

IFRS

£'000

£'000

£'000

£'000

£'000

£'000

Six months ended

30 June 2012

Analysis by activity

Continuing activity

Polymer Chemicals - Europe & North America

438,238

-

438,238

55,706

(13,831)

41,875

Polymer Chemicals - Asia & Rest of World

165,059

-

165,059

10,959

(3,121)

7,838

Total sales

603,297

-

603,297

Divisional operating profit

66,665

(16,952)

49,713

Unallocated corporate expenses

(4,576)

-

(4,576)

Operating profit / (loss)

62,089

(16,952)

45,137

 

Total sales*

Operating profit

Underlying performance

Special items

IFRS

Underlying performance

Special items

IFRS

£'000

£'000

£'000

£'000

£'000

£'000

Six months ended

30 June 2011

Analysis by activity

Continuing activity

Polymer Chemicals - Europe & North America

343,677

-

343,677

33,463

(10,797)

22,666

Polymer Chemicals - Asia & Rest of World

168,619

-

168,619

18,089

(1,030)

17,059

Total sales

512,296

-

512,296

Divisional operating profit / (loss)

51,552

(11,827)

39,725

Unallocated corporate expenses

(5,880)

(846)

(6,726)

Operating profit / (loss)

45,672

(12,673)

(32,999)

 

Total sales*

Operating profit

Underlying performance

Special items

IFRS

Underlying performance

Special items

IFRS

£'000

£'000

£'000

£'000

£'000

£'000

Year ended

31 December 2011

Analysis by activity

Continuing activity

Polymer Chemicals - Europe & North America

777,730

-

777,730

73,147

(36,781)

36,366

Polymer Chemicals - Asia & Rest of World

339,132

-

339,132

32,109

(3,831)

28,278

Total sales

1,116,862

-

1,116,862

Divisional operating profit

105,256

(40,612)

64,644

Unallocated corporate expenses

(8,888)

(1,427)

(10,315)

Operating profit / (loss)

96,368

(42,039)

54,329

*Includes share of revenue from joint ventures

 

5.  Reconciliation of profit / (loss) from operations to cash generated from operations

 

Six months ended

30 June 2012

Six months ended

 30 June 2011

Year ended

31 December 2011

Unaudited

Unaudited

Audited

£'000

£'000

£'000

Operating profit - continuing operations

45,137

32,999

54,329

Operating profit - discontinued operations

-

2,291

4,124

Less: share of profit of joint ventures

(2,179)

(1,759)

(3,533)

42,958

33,531

54,920

Adjustments for:

Depreciation and amortisation

9,527

9,324

22,841

Amortisation: special items

13,049

6,880

19,096

Restructuring and site closure - cash costs

2,456

4,516

15,792

- non-cash costs

637

-

4,438

Acquisition costs expensed in the period

-

846

1,427

Share based payments

407

-

1,269

(Profit) / loss on sale of fixed assets

239

(3)

(196)

Acquisition costs cash spent in period

(401)

(3,812)

(4,421)

Termination of interest swap acquired

-

-

(3,026)

Share based payments - cash settled

(6,431)

-

-

Cash impact of restructuring and site closure

(9,551)

(2,585)

(5,801)

Cash impact of termination of business

-

(451)

(422)

Pension funding in excess of IAS19 charge

(3,059)

(3,804)

(10,933)

(Increase) / decrease in inventories

(844)

(4,177)

7,320

Increase in trade and other receivables

(39,036)

(39,797)

(8,481)

Increase / (decrease) in trade and other payables

6,489

13,360

(13,632)

Cash generated from operations

16,440

13,828

80,191

 

6. Tax - continuing operations

Tax on the underlying profit before taxation for the six month period is charged at 24% (six months ended 30 June 2011: 20%; year ended 31 December 2011: 23%), representing the best estimate of the average annual effective income tax rate expected for the full year. Inclusion of the best estimate for the tax charge on the special items profit before taxation results in a tax rate of 26% (six months ended 30 June 2011: 8%; year ended 31 December 2011: 11%), on the IFRS profit before taxation for continuing operations.

 

7. Dividends

The interim dividend of 2.2p per ordinary share was approved by the Board on 28 August 2012 and will be paid on 8 November 2012 to members on the register at the close of business on 12 October 2012.

 

 

 

8. Earnings per share - continuing operations

 

Six months ended

30 June 2012

Six months ended

 30 June 2011

Year ended

31 December 2011

Unaudited

Unaudited

Audited

'000 shares

'000 shares

'000 shares

Weighted average number of shares in issue - basic

339,549

339,881

339,611

Weighted average number of shares in issue - diluted

345,016

346,910

347,127

 

 

Six months ended 30 June 2012

Six months ended 30 June 2011

Underlying performance

Special items

IFRS

Underlying performance

Special items

IFRS

£'000

£'000

£'000

£'000

£'000

£'000

Earnings (Profit / (loss) attributable to equity holders of the parent)

41,687

(14,065)

27,622

32,216

(8,552)

23,664

Earnings per share

12.3p

(4.2)p

8.1p

9.5p

(2.5)p

7.0p

Diluted earnings per share

12.1p

(4.1)p

8.0p

9.3p

(2.5)p

6.8p

 

Year ended 31 December 2011

Underlying performance

Special items

IFRS

£'000

£'000

£'000

Earnings (Profit attributable to equity holders of the parent)

63,712

(30,401)

33,311

Basic earnings per share

18.8p

(9.0)p

9.8p

Diluted earnings per share

18.4p

(8.8)p

9.6p

9. Defined benefit schemes

The defined benefit plan assets have been updated to reflect their market value as at the 30 June 2012. Differences between the expected return on assets and the actual return on assets have been recognised as an actuarial gain or loss in the Statement of Comprehensive Income in accordance with the Group's accounting policy.

 

10. Revision of fair value adjustments included in the June 2011 balance sheet

The June 2011 balance sheet as originally published included provisional estimates of the fair value adjustments resulting from the acquisition of PolymerLatex Deutschland Beteiligungsgesellschaft GmbH. These were amended for inclusion in the December 2011 balance sheet, following completion of the fair value evaluation process. The June 2011 balance sheet has been revised to incorporate these amendments.

 

11. Related party transactions

Transactions between the company and its subsidiaries, which are related parties, have been eliminated on consolidation and are not included in this note.

 

 

12. Seasonality

Historically, there has been no fixed pattern to seasonality in H1 compared to H2 performance in the Group, but, everything else being equal, because of the summer and Christmas break periods in Europe, management would expect the second half profits to be slightly weaker than the first half year.

 

13. Further information

The financial statements were approved by the Board of Directors on 28 August 2012.

This statement can be obtained by the public from the Company's registered office at Temple Fields, Harlow, Essex, CM20 2BH, or on the company website www.yulecatto.com.

 

14. Glossary of terms

Total sales

Total sales represent the total of revenue from Yule Catto & Co plc, its subsidiaries, and its share of the revenue of joint ventures.

EBITDA

EBITDA is calculated as operating profit before depreciation, amortisation and special items.

Operating profit

Operating profit represents profit from continuing activities before finance costs and taxation.

Special items

The following are disclosed separately as special items in order to provide a clearer indication of the Group's underlying performance:

·; Profit or loss impact arising from the sale or closure of an operation;

·; Amortisation of acquired intangible assets;

·; Impairment of non-current assets;

·; Costs of business combinations as defined by IFRS 3 and related debt issue costs;

·; Re-structuring and site closure costs;

·; Fair value adjustment - mark to market adjustments in respect of cross currency and interest rate derivatives used for hedging purposes where IAS 39 hedge accounting is not applied;

·; Amounts advanced in respect of invoices sold under non-recourse factoring arrangements;

·; Other non-recurring and non-operating items;

·; Tax impact of the above items; and

·; Settlement of prior period tax issues

Underlying performance

Underlying performance represents the statutory performance of the Group under IFRS, excluding special items.

Net borrowings

Net borrowings represents cash and cash equivalents together with short and long term borrowings, as adjusted for the effect of related derivative instruments, irrespective of whether they qualify for hedge accounting, and non-recourse factoring arrangements.

 

 

Responsibility statement

We confirm that to the best of our knowledge:

- The condensed set of financial statements has been prepared in accordance with IAS 34 'Interim Financial Reporting';

- The interim management report includes a fair review of the information required by DTR 4.2.7R (indication of important events during the first six months and description of principal risks and uncertainties for the remaining six months of the year); and

- The interim management report includes a fair review of the information required by DTR 4.2.8R (disclosure of related parties' transactions and changes therein).

 

By order of the Board

 

A M Whitfield D C Blackwood

Chief Executive Group Finance Director

28 August 2012

 

 

INDEPENDENT REVIEW REPORT TO YULE CATTO & CO PLC

We have been engaged by the company to review the interim consolidated financial results in the half-yearly financial report for the six months ended 30 June 2012, which comprises the Consolidated Income Statement, the Consolidated Statement of Comprehensive Income, the Consolidated Statement of Changes in Equity, the Consolidated Balance Sheet, the Consolidated Cash Flow Statement and the related notes. We have read the other information contained in the half-yearly financial report and considered whether it contains any apparent misstatements or material inconsistencies with the information in the interim consolidated financial statements.

Directors' responsibilities

The half-yearly financial report is the responsibility of, and has been approved by, the directors. The directors are responsible for preparing the half-yearly financial report in accordance with the Disclosure and Transparency Rules of the United Kingdom's Financial Services Authority.

As disclosed in note 2, the annual financial statements of the group are prepared in accordance with IFRSs as adopted by the European Union. The interim consolidated financial results included in this half-yearly financial report have been prepared in accordance with International Accounting Standard 34, "Interim Financial Reporting", as adopted by the European Union.

Our responsibility

Our responsibility is to express to the company a conclusion on the consolidated interim financial results in the half-yearly financial report based on our review. This report, including the conclusion, has been prepared for and only for the company for the purpose of the Disclosure and Transparency Rules of the Financial Services Authority and for no other purpose. We do not, in producing this report, accept or assume responsibility for any other purpose or to any other person to whom this report is shown or into whose hands it may come save where expressly agreed by our prior consent in writing.

Scope of review

We conducted our review in accordance with International Standard on Review Engagements (UK and Ireland) 2410, 'Review of Interim Financial Information Performed by the Independent Auditor of the Entity' issued by the Auditing Practices Board for use in the United Kingdom. A review of interim financial information consists of making enquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with International Standards on Auditing (UK and Ireland) and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion.

Conclusion

Based on our review, nothing has come to our attention that causes us to believe that the interim consolidated financial results in the half-yearly financial report for the six months ended 30 June 2012 are not prepared, in all material respects, in accordance with International Accounting Standard 34 as adopted by the European Union and the Disclosure and Transparency Rules of the United Kingdom's Financial Services Authority.

 

24 August 2012

PricewaterhouseCoopers LLPChartered Accountants and Statutory auditors

St Albans

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR BUGDIUDDBGDS
Date   Source Headline
1st May 20247:00 amRNSDivestment of Compounds completed
25th Apr 20244:30 pmRNSDirector/PDMR Shareholding
25th Apr 20244:20 pmRNSDirector/PDMR Shareholding
17th Apr 202410:43 amRNSTender offer results
15th Apr 20247:00 amRNSDivestment of Compounds
12th Apr 20247:00 amRNSPricing of senior notes
9th Apr 20243:47 pmRNSPre Stabilisation Notice
9th Apr 20248:09 amRNSNotice of tender offer
9th Apr 20248:09 amRNSProposed offering of senior notes
28th Mar 20242:38 pmRNSDirector/PDMR Shareholding
28th Mar 20242:38 pmRNSDirector/PDMR Shareholding
28th Mar 20242:10 pmRNSAnnual Financial Report and Notice of AGM
12th Mar 20247:00 amRNSFinal Results
30th Jan 20247:00 amRNSTrading Statement
17th Jan 20242:58 pmRNSExternal Appointment
15th Nov 20237:00 amRNSTrading statement - Autumn 2023
3rd Nov 20232:54 pmRNSDirector/PDMR Shareholding
23rd Oct 20231:58 pmRNSDirector/PDMR Shareholding
18th Oct 20237:00 amRNSDirector/PDMR Shareholding
17th Oct 20237:00 amRNSDirector/PDMR Shareholding
16th Oct 20233:13 pmRNSHolding(s) in Company - CORRECTION
16th Oct 202312:06 pmRNSHolding(s) in Company
16th Oct 202312:03 pmRNSHolding(s) in Company
16th Oct 202311:57 amRNSHolding(s) in Company
16th Oct 20237:00 amRNSTotal Voting Rights
16th Oct 20237:00 amRNSPDMR and PCA Notification
13th Oct 20234:18 pmRNSHolding(s) in Company
13th Oct 202310:48 amRNSHolding(s) in Company
13th Oct 20237:00 amRNSResult of rump placing
12th Oct 20234:36 pmRNSResult of Equity Issue
12th Oct 202310:09 amRNSHolding(s) in Company
11th Oct 20239:39 amRNSHolding(s) in Company
11th Oct 20237:00 amRNSPDMR PCA Notification
10th Oct 20233:04 pmRNSHolding(s) in Company
10th Oct 202310:26 amRNSHolding(s) in Company
10th Oct 202310:26 amRNSHolding(s) in Company
9th Oct 20233:08 pmRNSHolding(s) in Company
9th Oct 20239:44 amRNSHolding(s) in Company
6th Oct 20231:56 pmRNSHolding(s) in Company
6th Oct 20238:53 amRNSHolding(s) in Company
5th Oct 20232:40 pmRNSDirector/PDMR Shareholding
5th Oct 202312:27 pmRNSHolding(s) in Company
2nd Oct 20232:22 pmRNSHolding(s) in Company
28th Sep 20237:00 amRNSAdmission of Nil Paid Rights
27th Sep 20237:00 amRNSDespatch of PALs
26th Sep 20237:00 amRNSCapital Reorganisation
25th Sep 20231:58 pmRNSResults of General Meeting
22nd Sep 20233:21 pmRNSAdditional Listing
7th Sep 20233:44 pmRNSPublication of a Prospectus
7th Sep 20237:00 amRNSRights Issue

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.